St. Jude Study Links Radiation Therapy to Hearing Loss and Cognitive Decline in Ependymoma Patients
A study led by St. Jude Children's Research Hospital investigated the cognitive and communication abilities of children treated for ependymoma, a type of brain tumor. The research identified radiation therapy as a significant factor in hearing loss, which directly impacts cognitive health. Children experiencing severe hearing loss showed a greater decline in cognitive measures compared to those without.
The findings, published in Neuro-Oncology, emphasize the necessity of tailored cancer therapies that minimize side effects and encourage adherence to supportive interventions like hearing aids.
I. Study Scope and Key Findings
The study involved 145 children who received radiation therapy for ependymoma. Of these, 34% were diagnosed with severe hearing loss in at least one ear. Dr. Heather Conklin, from St. Jude's Department of Psychology & Biobehavioral Sciences, led the research.
The study found that hearing loss was associated with reduced intellectual ability and communication skills, as well as a greater long-term decline in intellectual ability. Interestingly, verbal learning and memory remained stable.
II. Insights on Radiation's Direct Impact
Dr. Conklin noted that while hearing loss-associated cognitive decline is often linked to combination therapies, this study observed a high rate of hearing loss and cognitive decline even in patients who only received radiation.
Higher rates of hearing loss in ependymoma patients are attributed to several factors, including younger age at diagnosis and the tumor's location, which often requires radiation treatment near the cochlea.
III. Associated Risk Factors for Hearing Loss
Researchers also linked severe hearing loss to:
- hydrocephalus
- multiple surgeries
- chemotherapy preceding radiation therapy
- young age
No associations were found with sex, race, or socio-economic status.
IV. Mitigation and Intervention Strategies
Interventions are available to mitigate hearing and cognitive deficits caused by treatment. These include:
- Medications designed to protect cochlear hair cells during chemotherapy.
- Advancements in radiation delivery, such as proton therapy, which offers more precision and can spare the cochlea from damage.
Post-treatment interventions have also significantly assisted patients. These include hearing aids, cochlear implants, and targeted academic supports. Improving adherence to these crucial interventions remains an ongoing objective.
V. The Role of Family Education
Parents surveyed in the study indicated they would prioritize hearing aid use more if they understood its positive impact on brain development. This highlights the critical importance of educating families about these risks to improve adherence to supportive care.